JAK pathway — Drug Target
All drugs that target JAK pathway — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (2)
- Chronic- PF-06480605 50 mg SC Q4W · Pfizer · JAK inhibitor · Immunology
- Induction- PF-06480605 150 mg SC Q4W · Pfizer · JAK inhibitor · Immunology
PF-06480605 is a medication for the treatment of inflammatory conditions, administered via subcutaneous injection every 4 weeks.